Jefferies Cuts PT on Mentor (MNT) from $45 to $36
More News related to MNT
- Mentor Announces Webcast of First Quarter Financial Results for Fiscal Year 2009
- Cowen & Co Starts Mentor (MNT) at Neutral
- Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes
- Mentor Corporation Declares Quarterly Dividend
- Mentor Announces Completion of Enrollment in Phase I Trial for Botulinum Toxin Type A in Patients with Cervical Dystonia
Jefferies lowers its price target on Mentor Corp. (NYSE: MNT) from $45 to $36.
Mentor Corporation engages in the development, manufacture, and marketing of various products serving the aesthetic medicine market.
Related Categories
Analyst CommentsStocks Mentioned
-0.48Related Entities
Sign up for StreetInsider Free!
Recieve full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
